We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

18 hedge funds and large institutions have $2.44M invested in Arcadia Biosciences in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

752% more capital inflows, than outflows

Capital inflows: $1.31M | Capital outflows: $154K

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

20% more funds holding

Funds holding: 15 → 18 (+3)

2.07% more ownership

Funds ownership: 6.05% → 8.12% (+2.1%)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$729K
2
GSA Capital Partners
GSA Capital Partners
United Kingdom
+$341K
3
Ardsley Advisory Partners
Ardsley Advisory Partners
Connecticut
+$84.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$58.9K
5
LPL Financial
LPL Financial
California
+$24.6K

Top Sellers

Rank Fund Capital Flow
1
Virtu Financial
Virtu Financial
New York
-$113K
2
Morgan Stanley
Morgan Stanley
New York
-$37.5K
3
BlackRock
BlackRock
New York
-$3.38K

RKDA Hedge Fund Activity: Q3 2020 in Review

18 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2020, worth a combined $2.44M — up 24% from $1.97M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new RKDA positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, adding an estimated $729K. The largest seller was Virtu Financial, exiting entirely with an estimated $113K sold.

  • 18 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2020, up from 15 in Q2 2020.
  • Funds reported $2.44M of Arcadia Biosciences stock for Q3 2020, up 24% quarter-over-quarter.
  • 5 funds opened new Arcadia Biosciences positions in Q3 2020 and 2 closed out, a net change of +3 holders.
  • The largest Arcadia Biosciences buyer in Q3 2020 was Sabby Management, an estimated $729K added.
  • The largest Arcadia Biosciences seller in Q3 2020 was Virtu Financial, an estimated $113K sold.

Based on aggregated 13F filings for Q3 2020.